John F. Paolini
CHIEF MEDICAL OFFICER · 4 filings · Latest: May 1, 2026
Kiniksa Pharmaceuticals International, plc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KNSA | John F. Paolini | CHIEF MEDICAL OFFICER | May 1, 2026 | Sale | $53.71 | 58,424 | $3.1M | 65,623 | |
KNSA | John F. Paolini | CHIEF MEDICAL OFFICER | May 1, 2026 | Option Exercise | $10.36 | 58,424 | $605.3K | 124,047 | |
KNSA | Paolini John F. | — | May 1, 2026 | Proposed Sale | $53.71 | 58,424 | $3.1M | — | |
KNSA | John F. Paolini | CHIEF MEDICAL OFFICER | Apr 7, 2026 | Option Exercise | — | 2,497 | — | 66,831 | |
KNSA | John F. Paolini | CHIEF MEDICAL OFFICER | Apr 1, 2026 | Option Exercise | — | 5,831 | — | 67,155 | |
KNSA | John F. Paolini | CHIEF MEDICAL OFFICER | Mar 2, 2026 | Sale | $44.82 | 40,000 | $1.8M | 61,324 | |
KNSA | John F. Paolini | CHIEF MEDICAL OFFICER | Mar 2, 2026 | Option Exercise | $10.36 | 40,000 | $414.4K | 101,324 | |
KNSA | Paolini John F. | — | Mar 2, 2026 | Proposed Sale | $44.82 | 40,000 | $1.8M | — | |
KNSA | Paolini John F. | — | Oct 31, 2025 | Proposed Sale | $37.14 | 82,542 | $3.1M | — | |
KNSA | Paolini John F. | — | Aug 6, 2025 | Proposed Sale | $32.55 | 29,325 | $954.5K | — | |
KNSA | Paolini John F. | — | May 7, 2025 | Proposed Sale | $27.00 | 29,525 | $797.2K | — | |
KNSA | Paolini John F. | — | Sep 3, 2024 | Proposed Sale | $26.12 | 90,217 | $2.4M | — |